Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Quedlinburg

10 clinical trials in Quedlinburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Quedlinburg at a glance
10
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Quedlinburg

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Permethrin
  • Sponsor:INFECTOPHARM Arzneimittel und Consilium GmbH
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG

Hidradenitis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:SODIUM BITUMINOSULFONATE DRY SUBSTANCE
  • Sponsor:Ichthyol-Gesellschaft Cordes Hermanni & Co. GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Universitaetsklinikum Essen AöR

Malignant melanoma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Psoriasis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pehero
  • Sponsor:Arctic Bioscience AS

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Quedlinburg

What the registry says about research in the country

01 Dermatology - Psoriasis Studies

Innovative research focusing on moderate to severe plaque psoriasis treatments, including evaluation of novel therapies like ESK-001 for long-term safety and effectiveness. Additional studies explore treatments for mild-to-moderate cases with oral medications.

  • Plaque Psoriasis Management
  • Long-term Treatment Safety
  • Novel Therapeutic Approaches

Multiple clinical trials aim to improve treatment outcomes and patient quality of life.

02 Dermatological Conditions

Comprehensive studies addressing various skin conditions, including atopic dermatitis and hidradenitis suppurativa. Research focuses on testing new therapeutic agents for effectiveness in managing moderate to severe cases.

  • Inflammatory Skin Conditions
  • Disease Severity Assessment
  • Treatment Response Evaluation

Trials aim to expand treatment options for challenging dermatological conditions.

03 Melanoma Research

Advanced studies in metastatic melanoma treatment, investigating combination therapies and novel approaches. Research includes both early-stage prevention and advanced disease management strategies.

  • Immunotherapy Combinations
  • Post-Surgery Treatment
  • Disease Progression Prevention

Trials focus on improving survival rates and treatment outcomes for melanoma patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.